Cancer Diagnostic Testing World Markets

Cancer Diagnostic Testing World Markets


May 1, 2013
336 Pages - SKU: TRI5033442
License type:
PDF E-mail From Publisher      US $3,400.00
Departmental Site License (one location, up to 10 users)      US $6,800.00
Global Site License Fulfilled by Publisher      US $10,200.00
Countries covered: Global

Cancer Diagnostic Testing World Markets

  enlarge


Cancer Diagnostic Testing World Markets

Cancer testing is one of the most important growth opportunities for the next three to five years in the diagnostics segment. The National Cancer Institute estimates that about ten million Americans have or have had some form of cancer. Overall costs of the disease are $126 billion annually. Pharmaceutical companies are developing more than 300 new medicines for cancer, some of which are in development for more than one type of the disease, for a total of more than 500 ongoing R&D projects.

The goal of this TriMark Publications report, Cancer Diagnostic Testing World Markets, is to review the market for tumor marker testing equipment and supplies using screening reagents and instruments for analysis of individual components in blood, serum or plasma. It defines the dollar volume of sales, both worldwide and in the U.S., and analyzes the factors that influence the size and the growth of the market segments. Also examined are the subsections of each market segment, including: the physician office labs, hospital labs and commercial laboratories. Additionally, the numbers of institutions using this type of testing and the factors that influence purchases are discussed. The report surveys almost all of the companies known to be marketing, manufacturing or developing instruments and reagents for the clinical point-of-care market in the U.S. Each company is discussed in depth with a section on its history, product line, business and marketing analysis, and a subjective commentary of the company’s market position.



More Hematology & Oncology reports by TriMark Publications

High-Growth Diagnostic Testing Markets by TriMark Publications
High-Growth Diagnostic Testing Markets There will be a steady increase in demand for new diagnostic testing services in the next five-year period, along with ...
Molecular Diagnostics in Cancer Testing by TriMark Publications
Molecular Diagnostics in Cancer Testing Molecular diagnostics is a rapidly-advancing area of research and medicine, with new technologies and applications being continually added. The technologies ...
Cytology and HPV Testing World Markets by TriMark Publications
Cancer is a group of diseases characterized by uncontrolled growth and spread of abnormal cells. If the spread is not controlled, it can result in ...
India's In Vitro Diagnostic Testing Industry by TriMark Publications
The TriMark Publications "Sector Snapshot" is designed to provide a high-level overview of a particular market sector, including key players, sales data and emerging trends. ...
See all reports like this >>

More Global Hematology & Oncology reports

Cervical Cancer Test Market & Patients - Pap Smear, HPV DNA, VIA – Test & Patients – Worldwide by Renub Research
Cervical Cancer Test Market & Patients - Pap Smear, HPV DNA, VIA – Test & Patients – Worldwide Cervical Cancer Test Market Overview Cervical ...
Medical Gases and Equipment Market by Gases (Oxygen, Medical Air, Nitrogen, Nitrous-oxide, Helium, Blood-gas Mixture, Nitrous Oxide-Oxygen Mixture), by Equipment (Cylinders, Manifolds, Regulators, Flowmeters) - Global Forecast to 2018 by MarketsandMarkets
Medical Gases and Equipment Market by Gases (Oxygen, Medical Air, Nitrogen, Nitrous-oxide, Helium, Blood-gas Mixture, Nitrous Oxide-Oxygen Mixture), by Equipment (Cylinders, Manifolds, Regulators, Flowmeters) - ...
2014 Strategies for the Global Tumor Marker Testing Market: US, Europe, Japan by Venture Planning Group
2014 Strategies for the Global Tumor Marker Testing Market: US, Europe, JapanHighlights- Identifies and evaluates major business opportunities emerging in the tumor marker market during ...
2014 Strategies for the Global Hematology and Flow Cytometry Markets by Venture Planning Group
2014 Strategies for the Global Hematology and Flow Cytometry Markets This comprehensive seven-country report contains 700 pages, 250 tables, and is designed to help ...
See all reports like this >>